H.R. 2071 · 117th Congress
Medicare Prescription Drug Price Negotiation Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
WelchSponsor12 cosponsors · 12 D
D
Castor
DC
D
Cicilline
RG
D
Grijalva
RG
D
Gallego
SL
D
Lynch
CM
D
Maloney
BM
D
McCollum
CP
D
Pingree
MP
D
Pocan
RR
D
Ruiz
DW
D
Wasserman Schultz
AS
D
Smith11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
What it does: CRS summary · Introduced in House · Mar 18, 2021
Medicare Prescription Drug Price Negotiation Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare Prescription Drug Price Negotiation Act of 2021
Latest action (Mar 19, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Mar 18, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.